Physician profile
Alan Durkin
NPI 1215136767
$547,846.96
in general payments reported to CMS, 2019-2025
19 companies · $17K in 2025
The $17K reported for 2025 was more than what 97% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $50K · 2020: $31K · 2021: $54K · 2022: $168K · 2023: $161K · 2024: $66K · 2025: $17K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $223K · Food and Beverage: $8,796 · Travel and Lodging: $7,215 · Grant: $4,450 · Long Term Medical Supply Or Device Loan: $326.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $223,353.69 |
| Food and Beverage | $8,796.06 |
| Travel and Lodging | $7,214.56 |
| Grant | $4,450.00 |
| Long Term Medical Supply Or Device Loan | $325.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $337,501.16 | 2021-2025 | |
| Merz North America, INC. | $192,088.11 | 2019-2025 | Xeomin |
| Allergan, INC. | $10,150.43 | 2019-2022 | |
| Abbvie INC. | $5,120.85 | 2023-2025 | Botox, Natrelle Saline-Filled Breast Implants |
| Mentor Worldwide LLC | $625.03 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Medela LLC | $561.20 | 2022-2023 | Invia Motion Endure |
| Revance Therapeutics, INC. | $415.52 | 2025 | Daxxify |
| Integra Lifesciences Corporation | $350.94 | 2024-2025 | Durasorb Monofilament Mesh, Integra, Integra Dermal Regeneration Template |
| Galderma Laboratories, L.P. | $183.93 | 2020-2022 | |
| Avita Medical Americas, LLC | $149.65 | 2025 | Cohealyx, Recell, Permeaderm |
| Pacira Pharmaceuticals Incorporated | $149.29 | 2020-2022 | |
| Polynovo North America LLC | $132.07 | 2024-2025 | Novosorb Btm |
| Depuy Synthes Sales INC. | $130.41 | 2025 | Na |
| Boston Scientific Corporation | $108.77 | 2020 | |
| Dilon Technologies, INC. | $91.15 | 2024 | Hemoblast Bellows |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $42.25 | 2022-2023 | Pico, Renasys Go V2 Home |
| Kerecis Limited | $19.99 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Novartis Pharmaceuticals Corporation | $13.18 | 2022 | |
| Baxter Healthcare | $13.03 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Durkin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.